PFIZER ACQUIRED COVX TO EXTEND BIOTHERAPEUTICS INVESTMENT 
(click here for additional information)

CovX is a biotechnology company creating long-acting biotherapeutics, CovX-Bodies.

CovX-Bodies combine the therapeutic potential of peptides with the beneficial clinical properties of antibodies.

CovX's has a number of clinical and pre-clinical programs for oncology and metabolic disorders.